Restoring order: YIII, EuIII, and ErIII tris(ligand) complexes of a new chiral alkoxide ligand, tBu2P(O)CH2CH(tBu)OH (HL), preferentially form as C3‐symmetric diastereomers. Thus racemic HL affords (RRR)‐ and (SSS)‐[LnL3] complexes, which are active catalysts for the stereoselective polymerization of rac‐lactide to afford highly isotactic polylactic acid.
The reaction of a chiral racemic bidentate ligand HL1 (tBu2P(O)CH2CH(tBu)OH) with mid to late trivalent lanthanide cations affords predominantly homochiral lanthanide complexes (RRR)-[Ln(L1)3] and (SSS)-[Ln(L1)3]. A series of reactions are reported that demonstrate that the syntheses are under thermodynamic control, and driven by a ligand 'self-recognition' process, in which the large asymmetric bidentate L1 ligands pack most favourably in a C3 geometry around the lanthanide cation. The synthesis of bis(L1) adducts [Ln(L1)2X] (X=N(SiMe3)2, OC6H3tBu-2,6) is also reported. Analysis of the diastereomer mixtures shows that homochiral (L1)2 complexes are favoured but to a lesser extent. The complexes Ln(L1)3 and [Ln(L1)2(OC6H3tBu-2,6)] have been studied as initiators for the polymerization of epsilon-caprolactone and its copolymer with lactide, glycolide and its copolymer with lactide, and epsilon-caprolactam.
In Ordnung gebracht: YIII‐, EuIII‐ und ErIII‐Tris(ligand)‐Komplexe des neuen chiralen Alkoxidliganden tBu2P(O)CH2CH(tBu)OH (HL) entstehen bevorzugt als C3‐symmetrische Diastereomere. Somit liefert racemisches HL (RRR)‐ und (SSS)‐[LnL3]‐Komplexe, die die stereoselektive Polymerisation von rac‐Lactid zu hoch isotaktischem Polylactid effektiv katalysieren.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.